122 related articles for article (PubMed ID: 14609305)
1. Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies.
Thijs L; Fagard R; Forette F; Nawrot T; Staessen JA
Acta Cardiol; 2003 Oct; 58(5):403-10. PubMed ID: 14609305
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
Khaw KT
J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Wu TT; Chen Y; Zhou Y; Adi D; Zheng YY; Liu F; Ma YT; Xie X
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28476876
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
Barrett-Connor E; Khaw KT; Yen SS
N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
[TBL] [Abstract][Full Text] [Related]
5. Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus.
Mauboussin JM; Mahamat A; Peyrière H; Rouanet I; Fabbro-Peray P; Daures JP; Vincent D
HIV Med; 2004 May; 5(3):151-7. PubMed ID: 15139980
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population.
Tilvis RS; Kähönen M; Härkönen M
Aging (Milano); 1999 Feb; 11(1):30-4. PubMed ID: 10337439
[TBL] [Abstract][Full Text] [Related]
7. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality.
Mazat L; Lafont S; Berr C; Debuire B; Tessier JF; Dartigues JF; Baulieu EE
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8145-50. PubMed ID: 11427700
[TBL] [Abstract][Full Text] [Related]
8. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.
Tamer C; Oksuz H; Söğüt S
Am J Ophthalmol; 2007 Feb; 143(2):212-216. PubMed ID: 17157799
[TBL] [Abstract][Full Text] [Related]
9. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
[TBL] [Abstract][Full Text] [Related]
10. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study.
Barrett-Connor E; Goodman-Gruen D
Circulation; 1995 Mar; 91(6):1757-60. PubMed ID: 7882484
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.
LaCroix AZ; Yano K; Reed DM
Circulation; 1992 Nov; 86(5):1529-35. PubMed ID: 1423966
[TBL] [Abstract][Full Text] [Related]
13. Predictors and clinical significance of declining plasma dehydroepiandrosterone sulfate in old age.
Kähönen MH; Tilvis RS; Jolkkonen J; Pitkälä K; Härkönen M
Aging (Milano); 2000 Aug; 12(4):308-14. PubMed ID: 11073351
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
[TBL] [Abstract][Full Text] [Related]
15. Do DHEA/DHEAS play a protective role in coronary heart disease?
Porsová-Dutoit I; Sulcová J; Stárka L
Physiol Res; 2000; 49 Suppl 1():S43-56. PubMed ID: 10984071
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study.
Tannenbaum C; Barrett-Connor E; Laughlin GA; Platt RW
Eur J Endocrinol; 2004 Dec; 151(6):717-25. PubMed ID: 15588238
[TBL] [Abstract][Full Text] [Related]
17. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
[TBL] [Abstract][Full Text] [Related]
18. Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women.
Forti P; Maltoni B; Olivelli V; Pirazzoli GL; Ravaglia G; Zoli M
Rejuvenation Res; 2012 Aug; 15(4):349-58. PubMed ID: 22524205
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
Birkenhäger-Gillesse EG; Derksen J; Lagaay AM
Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?
Beishuizen A; Thijs LG; Vermes I
Crit Care; 2002 Oct; 6(5):434-8. PubMed ID: 12398784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
